Yifan Pharmaceuticals (002019.SZ) has obtained a drug registration certificate.

Wisdom Finance and Economics APP News, Yifan Pharmaceuticals (002019.SZ) announced that its wholly-owned subsidiary, Hefei Yifan Biopharmaceutical Co., Ltd., received the Injection Of Isavuconazonium Sulfate "Drug Registration Certificate" issued by the National Medical Products Administration on September 15, 2025. Injection of isavuconazonium sulfate is an anti-infective drug suitable for the treatment of invasive aspergillosis and invasive mucormycosis in adult patients.